NCT05080322View on ClinicalTrials.gov

Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

December 1, 2024

Study Completion Date

January 1, 2025

Conditions
Allergic Rhinitis
Interventions
DRUG

Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray

on-demand INS (Fluticasone) combined with nasal spray AH1(Azelastine)

DRUG

Fluticasone Nasal 50 Mcg/Inh Nasal Spray

on-demand or maintenance

Trial Locations (1)

430030

RECRUITING

Tongji Hosptial affiliated to Tongji Medical college of Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

Zhongnan Hospital

OTHER

collaborator

The People's Hospital of Hebei Province

OTHER

lead

Zheng Liu ENT

OTHER